In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Lectus Therapeutics appoints new chairman

This article was originally published in Scrip

Executive Summary

The chairman and CEO of Ablynx, Dr Edwin Moses, has been appointed non-executive chairman of the UK drug discovery and development company Lectus Therapeutics. Professor Raymond Hill, who was, until April 2008, executive director of licensing and external research (Europe) for Merck, Sharp & Dohme Research Laboratories, has been named non-executive director. Lectus has also appointed Dr Chas Bountra chairman of, and Professor Annette Dolphin to, its scientific advisory board (SAB). Mr Bountra succeeds Professor Leslie Iversen, who has chaired the SAB since its first meeting in 2003.



Related Companies




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts